Novasep has formed a partnership with Triclinic Labs, a contract pharmaceutical and fine chemical solid-state development services company based in Lafayette, Indiana. The partnership joins Triclinic Labs’ early-stage, solid-state services with Novasep’s existing, early-stage, active pharmaceutical ingredient (API) synthesis and purification services.

The newly formed alliance will enable both parties to offer a full API development service, ranging from first chemical synthesis to solid-form optimization. Novasep’s services will be extended to include solid-form screening, selection, development, characterization, and analytical method development.

Source: Novasep